FDA NDC Directory · JSON-LD · Markdown

Risedronate Sodium

NDC 60723-041 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Labeler / ManufacturerHangzhou Minsheng Binjiang Pharmaceutical CO., Ltd
Marketing categoryAbbreviated NDA (generic) · App ANDA207516
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsRISEDRONATE SODIUM HEMI-PENTAHYDRATE (35 mg/1)
Marketing started20190401
Package count2

External sources

Source: openFDA. Public-domain (CC0).